2020 annual financial data
Marker Therapeutics 2020 Operating margin
Marker Therapeutics 2020 operating margin with verified reported values.
Direct answer
Operating margin was -6,188.29%.
Operating income was -28,886,000 USD and net income was -28,706,000 USD.
Operating cash flow was -20,034,691 USD.
Get free Marker Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 466,785 USD
- Operating income
- -28,886,000 USD
- Net income
- -28,706,000 USD
- Operating cash flow
- -20,034,691 USD